Share-based Payment Arrangement, Expense in USD of Bluejay Diagnostics, Inc. from 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bluejay Diagnostics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to Q3 2025.
  • Bluejay Diagnostics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $183.000, a 96.2% decline year-over-year.
  • Bluejay Diagnostics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was -$2.65K, a 137% decline year-over-year.
  • Bluejay Diagnostics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $20.1K, a 89.4% decline from 2023.
  • Bluejay Diagnostics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $189K, a 56.3% decline from 2022.
  • Bluejay Diagnostics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $433K, a 533% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Bluejay Diagnostics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$2.65K $183 -$4.61K -96.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-07
Q2 2025 $1.96K -$1.56K -$7.57K -126% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $9.53K $1.31K -$10.6K -89% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $20.1K -$2.58K +$13K +83.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $7.11K $4.79K +$47.3K Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-07
Q2 2024 -$40.2K $6.01K -$21.7K -78.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$18.5K $11.9K -$208K -94.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $189K -$15.6K -$103K -118% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $292K -$42.5K -$156K -138% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $448K $27.7K -$78.4K -73.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $472K $220K +$93.5K +74.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2023 $165K +$38.8K +30.8% Feb 1, 2023 Feb 28, 2023 10-Q 2023-11-09
Q4 2022 $433K $87.6K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $113K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $106K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $126K +$126K +76782% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-09
Q1 2021 $164 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09

Bluejay Diagnostics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $20.1K -$169K -89.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $189K -$244K -56.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $433K +$365K +533% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $68.5K +$61.1K +829% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $7.37K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.